ONO-0300302

• CAT Number: I033886
• CAS Number: 856689-51-5
• Molecular Formula: C29H35NO5
• Molecular Weight: 477.59
• Purity: ≥95%
• Synonyms: 3-[1-[(2S,3S)-2-(2,3-dihydro-1H-inden-2-ylmethyl)-3-(3,5-dimethoxy-4-methylphenyl)-3-hydroxypropyl]pyrrol-3-yl]propanoic acid
• InChI: InChI=1S/C29H35NO5/c1-19-26(34-2)15-24(16-27(19)35-3)29(33)25(14-21-12-22-6-4-5-7-23(22)13-21)18-30-11-10-20(17-30)8-9-28(31)32/h4-7,10-11,15-17,21,25,29,33H,8-9,12-14,18H2,1-3H3,(H,31,32)/t25-,29+/m0/s1
• InChIKey: USAXUWZJQPBEDO-ABYGYWHVSA-N
• SMILES: CC1=C(C=C(C=C1OC)[C@H]([C@@H](CC2CC3=CC=CC=C3C2)CN4C=CC(=C4)CCC(=O)O)O)OC

ONO-0300302（Cat No.:I033886）is a small-molecule compound under investigation for its potential therapeutic applications in oncology. It is a selective inhibitor targeting specific signaling pathways involved in cancer cell proliferation, survival, and metastasis. By modulating these pathways, ONO-0300302 aims to suppress tumor growth and enhance the effectiveness of other cancer treatments. Research suggests that it could be particularly useful in cancers with dysregulated growth signals, such as certain solid tumors. Currently in preclinical studies, ONO-0300302 holds promise as a targeted cancer therapy, offering a potential new option for patients with resistant or advanced cancers.